212 Ces Urol 2024; 28(3): 205–213 PŘEHLEDOVÉ ČLÁNKY 26. Dereziński P, Klupczynska A, Sawicki W, et al. Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study. Int J Med Sci [Internet]. 1. leden 2017 [citován 1. srpen 2024]; 14(1): 1–12. Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278653/. 27. Jentzmik F, Stephan C, Miller K, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Mar‑ ker in Prostate Cancer Detection and Identification of Aggressive Tumours. European Urology [Internet]. 1. červenec 2010 [citován 1. srpen 2024]; 58(1): 12–8. Dostupné z: https://www.sciencedirect.com/science/ article/pii/S0302283810000849. 28. Lind DS. Arginine and cancer. J Nutr. říjen 2004; 134(10 Suppl): 2837S–2841S; discussion 2853S. 29. Hsueh EC, Knebel SM, Lo WH, et al. Deprivation of arginine by recombinant human arginase in prostate cancer cells. J Hematol Oncol [Internet]. 30. duben 2012 [citován 8. srpen 2024]; 5: 17. Dostupné z: https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC3403903/. 30. Sivanand S, Vander Heiden MG. Emerging roles for branched chain amino acid metabolism in cancer. Cancer Cell [Internet]. 10. únor 2020 [citován 8. srpen 2024]; 37(2): 147–56. Dostupné z: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC7082774/. 31. Saini S. PSA and beyond: alternative prostate cancer biomarkers. Cell Oncol (Dordr) [Internet]. duben 2016 [citován 1. srpen 2024]; 39(2): 97–106. Dostupné z: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821699/. 32. Vlaeminck-Guillem V. Exosomes and prostate cancer management. Seminars in Cancer Biology [Internet]. 1. listopad 2022 [citován 22. září 2024]; 86: 101–11. Dostupné z: https://www.sciencedirect.com/ science/article/pii/S1044579X21002169. 33. McKiernan J, Donovan MJ, Margolis E, et al. A Prospective Adaptive Utility Trial to Validate Perfor‑ mance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy. European Urology [Internet]. 1. prosinec 2018 [citován 22. září 2024]; 74(6): 731–8. Dostupné z: https://www.sciencedirect.com/science/article/pii/ S0302283818306043. 34. Boehm BE, York ME, Petrovics G, Kohaar I, Chesnut GT. Biomarkers of Aggressive Prostate Cancer at Diagnosis. International Journal of Molecular Sciences [Internet]. leden 2023 [citován 22. září 2024]; 24(3): 2185. Dostupné z: https://www.mdpi.com/1422-0067/24/3/2185. 35. Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1. prosinec 1999; 59(23): 5975–9. 36. Deras IL, Aubin SMJ, Blase A, et al. PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Out‑ come. The Journal of Urology [Internet]. duben 2008 [citován 1. srpen 2024]; Dostupné z: https://www. auajournals.org/doi/10.1016/j.juro.2007. 11. 038. 37. Marks LS, Fradet Y, Lim Deras I, et al. PCA3 Molecular Urine Assay for Prostate Cancer in Men Under‑ going Repeat Biopsy. Urology [Internet]. 1. březen 2007 [citován 1. srpen 2024]; 69(3): 532–5. Dostupné z: https://www.sciencedirect.com/science/article/pii/S0090429506026380. 38. Haese A, de la Taille A, van Poppel H, et al. Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy. European Urology [Internet]. 1. listopad 2008 [citován 1. srpen 2024]; 54(5): 1081–8. Dostupné z: https://www.sciencedirect.com/science/article/pii/S0302283808007781. 39. Loeb S. Does PCA3 Help Identify Clinically Significant Prostate Cancer? European Urology [Internet]. 1. listopad 2008 [citován 1. srpen 2024]; 54(5): 980–1. Dostupné z: https://www.sciencedirect.com/science/ article/pii/S0302283808008531. 40. van Gils MPMQ, Hessels D, Hulsbergen-van de Kaa CA, et al. Detailed analysis of histopathological para‑ meters in radical prostatectomy specimens and PCA3 urine test results. Prostate. 1. srpen 2008; 68(11): 1215–22. 41. Filella X, Foj L, Milà M, et al. PCA3 in the detection and management of early prostate cancer. Tumour Biol. červen 2013; 34(3): 1337–47.
RkJQdWJsaXNoZXIy NDA4Mjc=